Investview, Inc.

Name: Investview, Inc. standardized financial statements, quarterly
Creator: Listed

INVUOTCCIK 862651IndustrialsFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$2.5m, Q2 FY2026

Operating income−$2.1m, Q2 FY2026

Net income−$3.2m, Q2 FY2026

Investview, Inc., income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$m	19.2	17.9	15.7	13.1	11.7	11.9	10.0	9.2	9.1	7.1	3.9	2.5
Cost of revenue	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Selling, general and administrative	$m	0.0	0.0	0.0	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Operating income	$m	2.2	0.8	1.9	0.5	(0.7)	0.1	(0.4)	0.4	(1.0)	(6.8)	(2.8)	(2.1)
Interest expense	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	0.0	not reported	not reported	not reported	0.0
Income tax	$m	0.3	1.1	0.5	0.3	0.1	0.0	0.0	0.0	0.0	(0.1)	0.0	0.0
Net income	$m	2.0	(0.2)	1.7	0.5	(0.8)	(0.2)	(0.7)	0.4	(0.9)	(7.8)	(3.9)	(3.2)
Diluted EPS	$ per share	0.00	not reported	0.00	0.00	0.00	not reported	0.00	0.00	0.00	not reported	0.00	not reported
Basic EPS	$ per share	0.00	not reported	0.00	0.00	0.00	not reported	0.00	0.00	0.00	not reported	0.00	not reported

Balance sheet

Cash and equivalents$2.0m, Q2 FY2026

Shareholders' equity$1.6m, Q2 FY2026

Investview, Inc., balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	22.5	20.9	24.4	23.7	24.5	22.5	17.5	16.2	15.1	10.0	4.5	2.0
Current assets	$m	28.0	24.5	27.8	29.5	30.8	27.4	25.2	24.0	20.9	13.0	7.6	4.6
Total assets	$m	38.6	33.7	35.8	33.6	32.9	31.6	29.9	29.5	27.5	21.5	17.5	13.5
Current liabilities	$m	13.9	12.0	14.8	12.6	13.4	12.3	11.0	9.9	8.5	6.1	5.9	5.5
Total liabilities	$m	19.9	14.9	18.7	15.8	15.7	14.4	13.1	12.1	10.8	12.6	12.3	11.9
Long-term debt	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Short-term borrowings	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Shareholders' equity	$m	18.6	18.8	17.1	17.9	17.2	17.2	16.8	17.4	16.6	8.9	5.2	1.6

Cash flow

Operating cash flow−$2.8m, Q2 FY2026

Capital expenditure$70.8k, Q2 FY2026

Investview, Inc., cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$k	1,809	265	4,800	5,476	2,747	979	(3,375)	(341)	609	(593)	(2,812)	(2,781)
Capital expenditure	$k	121	31.8	2.9	3.5	0.0	456	324	(182)	373	29.8	62.0	70.8
Dividends paid	$k	159	147	175	161	161	162	162	175	163	163	163	163
Share repurchases	$k	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported

Diluted shares (weighted)1.85bn, Q2 FY2026

Investview, Inc., shares, quarterly
Line item	Unit	Q3 FY20222022-09-30	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	m shares	2,641	3,673	3,673	3,669	3,089	2,897	1,861	1,859	2,895	1,853	1,847	1,847

Shares outstanding: 1.84bn at Aug 7, 2026, from the cover of the 10-Q filed Aug 14, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. Listed shows no prices and gives no investment advice.